{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:34:22Z","timestamp":1790523262680,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","schres-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.schres.2015.04.044","type":"journal-article","created":{"date-parts":[[2015,5,19]],"date-time":"2015-05-19T17:06:39Z","timestamp":1432055199000},"page":"640-648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Targeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stress"],"prefix":"10.1016","volume":"168","author":[{"given":"Roberto","family":"Frau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Abbiati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Bini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Casti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Devoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4498-9637","authenticated-orcid":false,"given":"Marco","family":"Bortolato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2015.04.044_bb0005","doi-asserted-by":"crossref","first-page":"18736","DOI":"10.1073\/pnas.0709419104","article-title":"Down-regulation of neurosteroid biosynthesis in corticolimbic circuits mediates social isolation-induced behavior in mice","volume":"104","author":"Agis-Balboa","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2\u20133","key":"10.1016\/j.schres.2015.04.044_bb0010","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.schres.2006.02.008","article-title":"Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia","volume":"84","author":"Akhondzadeh","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2015.04.044_bb0015","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1053\/meta.2001.25592","article-title":"Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16alpha-hydroxylation of 17beta-estradiol","volume":"50","author":"Badawi","year":"2001","journal-title":"Metabolism"},{"key":"10.1016\/j.schres.2015.04.044_bb0020","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0031-9384(99)00082-7","article-title":"Ontogeny of isolation rearing-induced deficits in sensorimotor gating in rats","volume":"67","author":"Bakshi","year":"1999","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.schres.2015.04.044_bb0025","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0028-3908(96)00067-6","article-title":"Isoniazid-induced inhibition of GABAergic transmission enhances neurosteroid content in the rat brain","volume":"35","author":"Barbaccia","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.schres.2015.04.044_bb0030","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0074-7742(01)46065-X","article-title":"Stress and neuroactive steroids","volume":"46","author":"Barbaccia","year":"2001","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.schres.2015.04.044_bb0035","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0306-4530(98)00071-7","article-title":"Neurosteroids: a novel function of the brain","volume":"23","author":"Baulieu","year":"1998","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.schres.2015.04.044_bb0040","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jsbmb.2012.08.009","article-title":"Determination of steroid metabolome as a possible tool for laboratory diagnosis of schizophrenia","volume":"133","author":"Bicikova","year":"2013","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.schres.2015.04.044_bb0045","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0006-3223(01)01211-2","article-title":"The role of neurotensin in the pathophysiology of schizophrenia and the mechanism of action of antipsychotic drugs","volume":"50","author":"Binder","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2015.04.044_bb0050","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/sj.npp.1300547","article-title":"Activation of D1, but not D2 receptors potentiates dizocilpine-mediated disruption of prepulse inhibition of the startle","volume":"30","author":"Bortolato","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2015.04.044_bb0070","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1176\/appi.ajp.2007.07060978","article-title":"Treatment of Tourette's syndrome with finasteride","volume":"164","author":"Bortolato","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2015.04.044_bb0065","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1038\/npp.2008.39","article-title":"Antipsychotic-like properties of 5 alpha-reductase inhibitors","volume":"33","author":"Bortolato","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2015.04.044_bb0060","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.neuropharm.2011.01.013","article-title":"Isolation rearing-induced reduction of brain 5\u03b1-reductase expression: relevance to dopaminergic impairments","volume":"60","author":"Bortolato","year":"2011","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.schres.2015.04.044_bb0055","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/JCP.0b013e3182549c2a","article-title":"Finasteride attenuates pathological gambling in patients with Parkinson disease","volume":"32","author":"Bortolato","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2015.04.044_bb0075","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/archpsyc.1992.01820030038005","article-title":"Gating and habituation of the startle reflex in schizophrenic patients","volume":"49","author":"Braff","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2015.04.044_bb0080","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1021\/ja953069t","article-title":"Mechanism-based inhibition of human steroid since 5\u03b1-reductase by finasteride: enzyme catalyzed formation of NADP-dihydrofinasteride, a potent bisubstrate analog inhibitor","volume":"118","author":"Bull","year":"1996","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.schres.2015.04.044_bb0085","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.neuint.2007.06.004","article-title":"Evaluation of neuroactive steroid levels by liquid chromatography\u2013tandem mass spectrometry in central and peripheral nervous system: effect of diabetes","volume":"52","author":"Caruso","year":"2008","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.schres.2015.04.044_bb0090","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.psyneuen.2012.06.008","article-title":"Regional distribution of 5\u03b1-reductase type 2 in the adult rat brain: an immunohistochemical analysis","volume":"38","author":"Castelli","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.schres.2015.04.044_bb0095","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/oxfordjournals.schbul.a007038","article-title":"The stress cascade and schizophrenia: etiology and onset","volume":"29","author":"Corcoran","year":"2003","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2015.04.044_bb0100","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.psyneuen.2011.09.018","article-title":"Inhibition of 5 alpha-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation","volume":"37","author":"Devoto","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.schres.2015.04.044_bb0105","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jpsychires.2004.08.005","article-title":"Plasma dehydroepiandrosterone levels are strongly increased in schizophrenia","volume":"39","author":"di Michele","year":"2005","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2015.04.044_bb0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1515\/REVNEURO.1994.5.1.27","article-title":"Modulation of brain dopamine transmission by sex steroids","volume":"5","author":"Di Paolo","year":"1994","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.schres.2015.04.044_bb0115","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1073\/pnas.051628598","article-title":"Brain 5alpha-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation","volume":"98","author":"Dong","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"30","key":"10.1016\/j.schres.2015.04.044_bb0120","doi-asserted-by":"crossref","first-page":"19786","DOI":"10.1074\/jbc.C109.016931","article-title":"Inhibition of human steroid 5beta-reductase (AKR1D1) by finasteride and structure of the enzyme inhibitor complex","volume":"284","author":"Drury","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.schres.2015.04.044_bb0125","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0306-4530(96)00006-6","article-title":"Endocrine and behavioral effects of airpuff-startle in rats","volume":"21","author":"Engelmann","year":"1996","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.schres.2015.04.044_bb0130","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.neubiorev.2008.03.003","article-title":"Behavioural and neurochemical effects of post-weaning social isolation in rodents\u2014 relevance to developmental neuropsychiatric disorders","volume":"32","author":"Fone","year":"2008","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"4","key":"10.1016\/j.schres.2015.04.044_bb0140","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.psyneuen.2012.07.014","article-title":"Inhibition of 5 alpha-reductase attenuates behavior effects of D1-, but not D2-like receptor agonists in C57BL\/6 mice","volume":"38","author":"Frau","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.schres.2015.04.044_bb0135","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.psyneuen.2013.09.014","article-title":"Inhibition of 17 alpha-hydroxylase\/C17,20 lyase reduces gating deficits consequent to dopaminergic activation","volume":"39","author":"Frau","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.schres.2015.04.044_bb0145","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.schres.2006.11.020","article-title":"Plasma cortisol\u2013dehydroepiandrosterone (DHEA) ratios in schizophrenia and bipolar disorder","volume":"90","author":"Gallagher","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2015.04.044_bb0155","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0006-3223(93)90180-L","article-title":"Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia","volume":"34","author":"Geyer","year":"1993","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2015.04.044_bb0150","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002130100811","article-title":"Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review","volume":"156","author":"Geyer","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.schres.2015.04.044_bb0160","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fnbeh.2014.00071","article-title":"Gene\u2013sex interactions in schizophrenia: focus on dopamine neurotransmission","volume":"8","author":"Godar","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.schres.2015.04.044_bb0165","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0091-3057(97)00510-8","article-title":"Isolation rearing in rats: pre- and postsynaptic changes in striatal dopaminergic systems","volume":"59","author":"Hall","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.schres.2015.04.044_bb0170","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/15622970109027500","article-title":"Movement disorder, memory, psychiatric symptoms and serum DHEA levels in schizophrenic and schizoaffective patients","volume":"2","author":"Harris","year":"2001","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2015.04.044_bb0175","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0301-0082(96)00003-2","article-title":"The central adaptation syndrome: psychosocial stress as a trigger for adaptive modifications of brain structure and brain function","volume":"48","author":"Huether","year":"1996","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.schres.2015.04.044_bb0180","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/01.yco.0000218603.25346.8f","article-title":"Apoptosis in schizophrenia: pathophysiologic and therapeutic considerations","volume":"19","author":"Jarskog","year":"2006","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.schres.2015.04.044_bb0185","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0149-7634(05)80175-7","article-title":"Mechanisms of stress: a dynamic overview of hormonal and behavioral homeostasis","volume":"16","author":"Johnson","year":"1992","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.schres.2015.04.044_bb0190","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0091-3057(92)90635-S","article-title":"Dopaminergic and serotonergic function following isolation rearing in rats: study of behavioural responses and postmortem and in vivo neurochemistry","volume":"43","author":"Jones","year":"1992","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.schres.2015.04.044_bb0195","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.psyneuen.2005.07.002","article-title":"The effects of sex and hormonal status on the physiological response to acute psychosocial stress","volume":"31","author":"Kajantie","year":"2006","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.schres.2015.04.044_bb0200","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-2008-1058110","article-title":"Improvement of general symptoms in a chronic psychotic patient treated with finasteride: case report","volume":"41","author":"Koethe","year":"2008","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.schres.2015.04.044_bb0205","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0039-128X(96)00174-2","article-title":"The key role of 17 beta-hydroxysteroid dehydrogenases in sex steroid biology","volume":"62","author":"Labrie","year":"1997","journal-title":"Steroids"},{"key":"10.1016\/j.schres.2015.04.044_bb0210","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.pbb.2003.11.011","article-title":"Long-term social isolation and medial prefrontal cortex: dopaminergic and cholinergic neurotransmission","volume":"77","author":"Leng","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.schres.2015.04.044_bb0225","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/sj.npp.1300952","article-title":"Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeutics","volume":"31","author":"Marx","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2015.04.044_bb0220","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/npp.2009.26","article-title":"Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia","volume":"34","author":"Marx","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2015.04.044_bb0215","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neuroscience.2011.06.076","article-title":"Pregnenolone as a novel therapeutic candidate in schizophrenia: emerging preclinical and clinical evidence","volume":"191","author":"Marx","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.schres.2015.04.044_bb0230","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0165-0173(01)00112-6","article-title":"The interaction between neuroactive steroids and the sigma1 receptor function: behavioral consequences and therapeutic opportunities","volume":"37","author":"Maurice","year":"2001","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.schres.2015.04.044_bb0235","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0074-7742(01)46058-2","article-title":"Biosynthesis of neurosteroids and regulation of their synthesis","volume":"46","author":"Mellon","year":"2001","journal-title":"Int. Rev. Neurobiol."},{"issue":"11","key":"10.1016\/j.schres.2015.04.044_bb0240","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/mds.23810","article-title":"A preliminary study of finasteride in Tourette syndrome","volume":"26","author":"Muroni","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.schres.2015.04.044_bb0245","doi-asserted-by":"crossref","first-page":"18676","DOI":"10.1073\/pnas.1008911107","article-title":"Direct involvement of sigma-1 receptors in the dopamine D1 receptor-mediated effects of cocaine","volume":"107","author":"Navarro","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.schres.2015.04.044_bb0250","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1192\/bjp.162.2.166","article-title":"Stressful life events and schizophrenia. II: Conceptual and methodological issues","volume":"162","author":"Norman","year":"1993","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2015.04.044_bb0255","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/schbul\/18.3.387","article-title":"Developmental processes in schizophrenic disorders: longitudinal studies of vulnerability and stress","volume":"18","author":"Nuechterlein","year":"1992","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2015.04.044_bb0260","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2174\/138161211795049589","article-title":"Steroid 5\u03b1-reductase as a novel therapeutic target for schizophrenia and other neuropsychiatric disorders","volume":"17","author":"Paba","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.schres.2015.04.044_bb0265","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.schres.2015.04.044_bb0270","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1007\/s11064-008-9718-5","article-title":"Neurosteroid biosynthesis regulates sexually dimorphic fear and aggressive behavior in mice","volume":"33","author":"Pinna","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.schres.2015.04.044_bb0275","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0306-4522(03)00122-2","article-title":"Dopamine depletion of the nucleus accumbens reverses isolation-induced deficits in prepulse inhibition in rats","volume":"119","author":"Powell","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.schres.2015.04.044_bb0280","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1073\/pnas.88.10.4553","article-title":"Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain","volume":"88","author":"Purdy","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl. 2","key":"10.1016\/j.schres.2015.04.044_bb0285","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0306-4530(02)00126-9","article-title":"Effects of estrogen on brain development and neuroprotection \u2014 implications for negative symptoms in schizophrenia","volume":"28","author":"Rao","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.schres.2015.04.044_bb0305","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jpsychires.2009.07.002","article-title":"Neurocognitive deficits in schizophrenia are associated with alterations in blood levels of neurosteroids: a multiple regression analysis of findings from a double-blind, randomized, placebo-controlled, crossover trial with DHEA","volume":"44","author":"Ritsner","year":"2010","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2015.04.044_bb0290","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.euroneuro.2006.09.001","article-title":"State and trait related predictors of serum cortisol to DHEA(S) molar ratios and hormone concentrations in schizophrenia patients","volume":"17","author":"Ritsner","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2015.04.044_bb0300","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/pcn.12150","article-title":"Pregnenolone treatment reduces severity of negative symptoms in recent-onset schizophrenia: an 8-week, double-blind, randomized add-on two-center trial","volume":"68","author":"Ritsner","year":"2014","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2015.04.044_bb0310","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1471-4159.2008.05806.x","article-title":"Gating deficits in isolation-reared rats are correlated with alterations in protein expression in nucleus accumbens","volume":"108","author":"Roncada","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.schres.2015.04.044_bb0320","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.neuint.2007.07.019","article-title":"Effects of swim stress on mRNA and protein levels of steroid 5alpha-reductase isozymes in prefrontal cortex of adult male rats","volume":"52","author":"Sanchez","year":"2008","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.schres.2015.04.044_bb0325","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.yhbeh.2009.07.001","article-title":"Effects of environmental stress on mRNA and protein expression levels of steroid 5alpha-reductase isozymes in adult rat brain","volume":"56","author":"Sanchez","year":"2009","journal-title":"Horm. Behav."},{"key":"10.1016\/j.schres.2015.04.044_bb0330","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1046\/j.1471-4159.2000.0750732.x","article-title":"Social isolation-induced decreases in both the abundance of neuroactive steroids and GABA(A) receptor function in rat brain","volume":"75","author":"Serra","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.schres.2015.04.044_bb0335","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0920-9964(01)00367-X","article-title":"Correlation of plasma neurosteroid levels to the severity of negative symptoms in male patients with schizophrenia","volume":"58","author":"Shirayama","year":"2002","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2015.04.044_bb0340","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jpsychires.2005.01.008","article-title":"Blood DHEAS concentrations correlate with cognitive function in chronic schizophrenia patients: a pilot study","volume":"39","author":"Silver","year":"2005","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2015.04.044_bb0350","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1001\/archpsyc.60.2.133","article-title":"Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia","volume":"60","author":"Strous","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2015.04.044_bb0345","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.schres.2004.03.005","article-title":"Increased circulatory dehydroepiandrosterone and dehydroepiandrosterone-sulphate in first-episode schizophrenia: relationship to gender, aggression and symptomatology","volume":"71","author":"Strous","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2015.04.044_bb0355","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00008877-200006000-00002","article-title":"Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon","volume":"11","author":"Swerdlow","year":"2000","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.schres.2015.04.044_bb0360","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev.clinpsy.4.022007.141248","article-title":"Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia","volume":"4","author":"Walker","year":"2008","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.schres.2015.04.044_bb0365","doi-asserted-by":"crossref","first-page":"51455","DOI":"10.1371\/journal.pone.0051455","article-title":"Pregnenolone rescues schizophrenia-like behavior in dopamine transporter knockout mice","volume":"7","author":"Wong","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.schres.2015.04.044_bb0370","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2165\/00023210-200115040-00004","article-title":"Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications","volume":"15","author":"Yao","year":"2001","journal-title":"CNS Drugs"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996415002613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996415002613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T04:54:01Z","timestamp":1566708841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996415002613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0920996415002613"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2015.04.044","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stress","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2015.04.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}